CLINICAL_TRIALS
trial_result
· 2016-04-26
Clinical Trial Update: Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma [Phase 2]
Summary
Phase 2 clinical trial results assess the efficacy and safety of reslizumab for poorly controlled asthma; results have been posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ception Therapeutics | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2016-04-26